Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.
Combination therapies that include metronidazole (MTZ) are the most successful therapies used in eradicating Helicobacter pylori. In this study, the prevalence and the relevance of heterogeneity in susceptibility to MTZ among H. pylori populations of 156 patients were evaluated. The results of this...
Tallennettuna:
| Julkaisussa: | J Clin Microbiol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1996
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC229209/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8862577/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.34.9.2158-2162.1996 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|